secwatch.observer — SEC 8-K summary
======================================

Issuer:     LivaNova PLC (LIVN)
CIK:        0001639691
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0001639691-23-000010
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LivaNova Q4 revenue up 6.2% constant currency; adjusted EPS $0.81
-----------------------------------------------------------------

- Q4 revenue $274.9M (+6.2% constant currency); GAAP EPS $0.03, adjusted EPS $0.81.
- FY2022 revenue $1.02B (+2.9% constant currency); GAAP loss per share $1.61, adjusted EPS $2.39.
- First clinical cases of Essenz perfusion system completed; LifeSPARC ECMO 510(k) cleared.
- FDA Warning Letter for Munich facility and 3T Heater-Cooler closed out.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000010/0001639691-23-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1639691/000163969123000010/livn-20230215.htm
  HTML page:      https://secwatch.observer/filing/0001639691-23-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer